Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Reproducible Findings in Systematic Reviews and Meta-analyses in Oncology: Verify, Then Trust.

Unger JM.

JAMA Oncol. 2019 Sep 5. doi: 10.1001/jamaoncol.2019.2664. [Epub ahead of print] No abstract available.

PMID:
31486827
2.

Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications.

Unger JM, Nghiem VT, Hershman DL, Vaidya R, LeBlanc M, Blanke CD.

JAMA Netw Open. 2019 Sep 4;2(9):e1910593. doi: 10.1001/jamanetworkopen.2019.10593.

PMID:
31483471
3.

A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events.

Lee SM, Miao J, Wu R, Unger JM, Cheung K, Hershman DL.

Health Qual Life Outcomes. 2019 Aug 22;17(1):146. doi: 10.1186/s12955-019-1210-1.

4.

Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018.

Loree JM, Anand S, Dasari A, Unger JM, Gothwal A, Ellis LM, Varadhachary G, Kopetz S, Overman MJ, Raghav K.

JAMA Oncol. 2019 Aug 15:e191870. doi: 10.1001/jamaoncol.2019.1870. [Epub ahead of print]

PMID:
31415071
5.

Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims.

Barzi A, Hershman DL, Till C, Barlow WE, Ramsey S, Lenz HJ, Hochster HS, Unger JM.

Arch Osteoporos. 2019 Jul 28;14(1):83. doi: 10.1007/s11657-019-0629-7.

PMID:
31352608
6.

Reimbursing Patients for Participation in Cancer Clinical Trials.

Unger JM, Fleury ME.

JAMA Oncol. 2019 Jul 1;5(7):932-934. doi: 10.1001/jamaoncol.2019.0141. No abstract available.

PMID:
31169875
7.

The Effects of Ganglioside-Monosialic Acid in Taxane-induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial.

Su Y, Huang J, Wang S, Unger JM, Arias-Fuenzalida J, Shi Y, Li J, Gao Y, Shi W, Wang X, Peng R, Xu F, An X, Xue C, Xia W, Hong R, Zhong Y, Lin Y, Huang H, Zhang A, Zhang L, Cai L, Zhang J.

J Natl Cancer Inst. 2019 May 15. pii: djz086. doi: 10.1093/jnci/djz086. [Epub ahead of print]

PMID:
31093677
8.

Sociodemographic, clinical and birth hospitalization characteristics and infant Hepatitis B vaccination in Washington State.

Oster NV, Williams EC, Unger JM, Newcomb PA, Jacobson EN, deHart MP, Englund JA, Hofstetter AM.

Vaccine. 2019 Sep 10;37(38):5738-5744. doi: 10.1016/j.vaccine.2019.03.050. Epub 2019 Mar 28.

PMID:
30930007
9.

Religiosity, Social Support, and Ethnic Identity: Exploring "Resilience Resources" for African-American Women Experiencing HIV-Related Stigma.

Lipira L, Williams EC, Nevin PE, Kemp CG, Cohn SE, Turan JM, Simoni JM, Andrasik MP, French AL, Unger JM, Heagerty P, Rao D.

J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):175-183. doi: 10.1097/QAI.0000000000002006.

PMID:
30865171
10.

Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202.

Henry NL, Unger JM, Till C, Schott AF, Crew KD, Lew DL, Fisch MJ, Moinpour CM, Wade JL 3rd, Hershman DL.

Cancer. 2019 Jun 15;125(12):2123-2129. doi: 10.1002/cncr.32024. Epub 2019 Mar 12.

PMID:
30861098
11.

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.

Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME.

J Natl Cancer Inst. 2019 Mar 1;111(3):245-255. doi: 10.1093/jnci/djy221.

12.

Lung Cancer Screening in the National Cancer Institute Community Oncology Research Program: Availability and Service Organization.

Carlos RC, Sicks JD, Chiles C, Gansauer L, Kamen CS, Kazak AE, Neuman HB, Unger JM, Weaver KE.

J Am Coll Radiol. 2019 Apr;16(4 Pt A):427-434. doi: 10.1016/j.jacr.2018.12.016. Epub 2019 Feb 26.

PMID:
30819455
13.

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices.

Ramsey SD, Unger JM, Baker LH, Little RF, Loomba R, Hwang JP, Chugh R, Konerman MA, Arnold K, Menter AR, Thomas E, Michels RM, Jorgensen CW, Burton GV, Bhadkamkar NA, Hershman DL.

JAMA Oncol. 2019 Apr 1;5(4):497-505. doi: 10.1001/jamaoncol.2018.6437. Erratum in: JAMA Oncol. 2019 Mar 7;:.

PMID:
30653226
14.

Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials.

Unger JM, Moseley A, Symington B, Chavez-MacGregor M, Ramsey SD, Hershman DL.

JAMA Netw Open. 2018 Aug 3;1(4):e181235. doi: 10.1001/jamanetworkopen.2018.1235.

15.

Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.

Unger JM, Hershman DL, Fleury ME, Vaidya R.

JAMA Oncol. 2019 Mar 1;5(3):326-333. doi: 10.1001/jamaoncol.2018.5953. Erratum in: JAMA Oncol. 2019 Feb 14;:.

PMID:
30629092
16.

Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups.

Cathcart-Rake EJ, Zemla T, Jatoi A, Weaver KE, Neuman H, Kazak AE, Carlos R, Gansauer L, Unger JM, Pajewski NM, Kamen C.

Cancer. 2019 Apr 15;125(8):1313-1318. doi: 10.1002/cncr.31925. Epub 2018 Dec 18.

PMID:
30561776
17.

Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.

Hershman DL, Unger JM, Crew K.

JAMA. 2018 Dec 4;320(21):2270-2271. doi: 10.1001/jama.2018.16744. No abstract available.

PMID:
30512095
18.

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).

Mongiovi JM, Zirpoli GR, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Thomas Budd G, Albain KS, Ambrosone CB, McCann SE.

Breast Cancer Res. 2018 Nov 28;20(1):146. doi: 10.1186/s13058-018-1077-9.

19.

Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.

Moore HCF, Unger JM, Phillips KA, Boyle F, Hitre E, Moseley A, Porter DJ, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow JR, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian LM, Meyskens FL, Gelber RD, Hortobagyi GN, Albain KS.

J Natl Cancer Inst. 2019 Feb 1;111(2):210-213. doi: 10.1093/jnci/djy185.

20.

HIV-Related Stigma and Viral Suppression Among African-American Women: Exploring the Mediating Roles of Depression and ART Nonadherence.

Lipira L, Williams EC, Huh D, Kemp CG, Nevin PE, Greene P, Unger JM, Heagerty P, French AL, Cohn SE, Turan JM, Mugavero MJ, Simoni JM, Andrasik MP, Rao D.

AIDS Behav. 2019 Aug;23(8):2025-2036. doi: 10.1007/s10461-018-2301-4.

PMID:
30343422
21.

Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).

Shen S, Unger JM, Crew KD, Till C, Greenlee H, Gralow J, Dakhil SR, Minasian LM, Wade JL 3rd, Fisch MJ, Henry NL, Hershman DL.

Breast Cancer Res Treat. 2018 Dec;172(3):603-610. doi: 10.1007/s10549-018-4946-0. Epub 2018 Aug 29.

PMID:
30159789
22.

Reply to T.P. Houston et al.

Hershman DL, Unger JM.

J Clin Oncol. 2018 Sep 20;36(27):2810-2811. doi: 10.1200/JCO.18.00285. Epub 2018 Jul 23. No abstract available.

PMID:
30036115
23.

Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.

Hershman DL, Unger JM, Greenlee H, Capodice JL, Lew DL, Darke AK, Kengla AT, Melnik MK, Jorgensen CW, Kreisle WH, Minasian LM, Fisch MJ, Henry NL, Crew KD.

JAMA. 2018 Jul 10;320(2):167-176. doi: 10.1001/jama.2018.8907.

24.

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421).

Unger JM, Griffin K, Donaldson GW, Baranowski KM, Good MJ, Reburiano E, Hussain M, Monk PJ, Van Veldhuizen PJ, Carducci MA, Higano CS, Lara PN, Tangen CM, Quinn DI, Wade JL III, Vogelzang NJ, Thompson IM Jr, Moinpour CM.

J Patient Rep Outcomes. 2018 Jun 13;2:27. doi: 10.1186/s41687-018-0054-5. eCollection 2017.

25.

The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials.

Unger JM, Barlow WE, Tangen CM, Ramsey SD, Thompson IM Jr, Klein EA, LeBlanc M, Blanke CD, Goodman PJ, Minasian LM, Nghiem VT, Hershman DL.

Cancer Epidemiol. 2018 Aug;55:117-122. doi: 10.1016/j.canep.2018.06.005. Epub 2018 Jun 21.

26.

Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.

Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, Boni L, Unger JM, Anderson RA, Mehta K, Minton S, Poggio F, Albain KS, Adamson DJA, Gerber B, Cripps A, Bertelli G, Seiler S, Ceppi M, Partridge AH, Del Mastro L.

J Clin Oncol. 2018 Jul 1;36(19):1981-1990. doi: 10.1200/JCO.2018.78.0858. Epub 2018 May 2.

PMID:
29718793
27.

Association of Cardiovascular Risk Factors With Cardiac Events and Survival Outcomes Among Patients With Breast Cancer Enrolled in SWOG Clinical Trials.

Hershman DL, Till C, Shen S, Wright JD, Ramsey SD, Barlow WE, Unger JM.

J Clin Oncol. 2018 Sep 10;36(26):2710-2717. doi: 10.1200/JCO.2017.77.4414. Epub 2018 Mar 27.

28.

Key design and analysis principles for quality of life and patient-reported outcomes in clinical trials.

Unger JM, Vaidya R, Gore JL.

Urol Oncol. 2019 May;37(5):324-330. doi: 10.1016/j.urolonc.2018.02.012. Epub 2018 Mar 21. Review.

PMID:
29572075
29.

Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.

Zirpoli GR, McCann SE, Sucheston-Campbell LE, Hershman DL, Ciupak G, Davis W, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Budd GT, Albain KS, Ambrosone CB.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx098.

30.

Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.

Unger JM, Hershman DL, Till C, Tangen CM, Barlow WE, Ramsey SD, Goodman PJ, Thompson IM Jr.

J Natl Cancer Inst. 2018 Nov 1;110(11):1208-1215. doi: 10.1093/jnci/djy035.

31.

Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials.

Chavez-MacGregor M, Unger JM, Moseley A, Ramsey SD, Hershman DL.

Cancer. 2018 Apr 15;124(8):1760-1769. doi: 10.1002/cncr.31241. Epub 2018 Jan 25.

32.

Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).

Hershman DL, Unger JM, Crew KD, Till C, Greenlee H, Minasian LM, Moinpour CM, Lew DL, Fehrenbacher L, Wade JL 3rd, Wong SF, Fisch MJ, Lynn Henry N, Albain KS.

J Natl Cancer Inst. 2018 Jun 1;110(6):669-676. doi: 10.1093/jnci/djx259.

33.

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.

Henry NL, Unger JM, Schott AF, Fehrenbacher L, Flynn PJ, Prow DM, Sharer CW, Burton GV, Kuzma CS, Moseley A, Lew DL, Fisch MJ, Moinpour CM, Hershman DL, Wade JL 3rd.

J Clin Oncol. 2018 Feb 1;36(4):326-332. doi: 10.1200/JCO.2017.74.6651. Epub 2017 Nov 14.

34.

Estimating global treatment toxicity burden from adverse-event data.

Lee SM, Hershman DL, Miao J, Zhong X, Unger JM, Cheung YKK.

Cancer. 2018 Feb 15;124(4):858-864. doi: 10.1002/cncr.31107. Epub 2017 Nov 7.

35.

History of Diabetes and Survival Outcome Among Participants 65 Years or Older in SWOG Clinical Trials.

Hershman DL, Till C, Wright JD, Ramsey S, Barlow WE, Unger JM.

JCO Clin Cancer Inform. 2017 Nov;1:1-12. doi: 10.1200/CCI.17.00040.

36.

Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630.

Potkul RK, Unger JM, Livingston RB, Crew KD, Wilczynski SP, Salomon CG, Smith BL, Wong L, Campbell DL, Einspahr DE, Anderson GL, Hershman D, Goodman GE, Brown PH, Meyskens FL, Albain KS.

NPJ Breast Cancer. 2016 Aug 10;2:16024. doi: 10.1038/npjbcancer.2016.24. eCollection 2016.

37.

Using Delayed Toxicities to Re-evaluate Tolerability in Phase 2 Trials: A Case Example using Bortezomib.

Lee SM, Zhang Y, Minasian LM, Unger JM, Hershman DL.

Cancer Invest. 2017 Aug 9;35(7):484-489. doi: 10.1080/07357907.2017.1340479. Epub 2017 Jul 10.

PMID:
28692317
38.

How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?

Crew KD, Albain KS, Hershman DL, Unger JM, Lo SS.

NPJ Breast Cancer. 2017 May 19;3:20. doi: 10.1038/s41523-017-0021-y. eCollection 2017.

39.

The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population.

Unger JM, LeBlanc M, Blanke CD.

JAMA Oncol. 2017 Oct 1;3(10):1345-1351. doi: 10.1001/jamaoncol.2017.0762.

40.

Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials.

Greenlee H, Unger JM, LeBlanc M, Ramsey S, Hershman DL.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):21-29. doi: 10.1158/1055-9965.EPI-15-1336. Epub 2016 Dec 16. Review.

41.

Dental health status and patient-reported outcomes at baseline in patients participating in the osteonecrosis of the jaw registry study, SWOG S0702.

Van Poznak CH, Darke A, Moinpour CM, Bagramian RA, Schubert MM, Gralow JR, Wade JL 3rd, Unger JM.

Support Care Cancer. 2017 Apr;25(4):1191-1199. doi: 10.1007/s00520-016-3509-3. Epub 2016 Dec 7.

42.

Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer.

Lambertini M, Falcone T, Unger JM, Phillips KA, Del Mastro L, Moore HC.

J Clin Oncol. 2017 Mar;35(7):804-805. doi: 10.1200/JCO.2016.69.2582. Epub 2016 Nov 28. No abstract available.

PMID:
27893335
43.

Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.

Unger JM, Till C, Thompson IM Jr, Tangen CM, Goodman PJ, Wright JD, Barlow WE, Ramsey SD, Minasian LM, Hershman DL.

J Natl Cancer Inst. 2016 Aug 26;108(12). pii: djw168. doi: 10.1093/jnci/djw168. Print 2016 Dec.

44.

Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208.

Moinpour CM, Unger JM, Ganz PA, Kornblith AB, Gaynor ER, Bowers MA, Gatti GS, Kaminski MS, Erba HP, Wang T, Yoon J, Press OW, Fisher RI.

J Cancer Surviv. 2017 Feb;11(1):32-40. doi: 10.1007/s11764-016-0559-y. Epub 2016 Jul 12.

45.

Measuring the Real Clinical Impact of Randomized Clinical Trials in Oncology-Reply: Beyond Citation Counts.

Unger JM, Barlow WE, Hershman DL.

JAMA Oncol. 2016 Nov 1;2(11):1511. doi: 10.1001/jamaoncol.2016.1772. No abstract available.

PMID:
27355398
46.

The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.

Unger JM, Cook E, Tai E, Bleyer A.

Am Soc Clin Oncol Educ Book. 2016;35:185-98. doi: 10.14694/EDBK_156686.

47.

Adverse Health Effects of Intermittent vs Continuous Androgen Deprivation Therapy for Metastatic Prostate Cancer-Reply.

Hershman DL, Unger JM.

JAMA Oncol. 2016 May 1;2(5):686-7. doi: 10.1001/jamaoncol.2016.0370. No abstract available.

PMID:
27244679
48.

Laparoscopic Total Gastrectomy with D2 Lymphadenectomy and Side-to-Side Stapled Esophagojejunostomy.

Treitl D, Hochwald SN, Bao PQ, Unger JM, Ben-David K.

J Gastrointest Surg. 2016 Aug;20(8):1523-9. doi: 10.1007/s11605-016-3162-7. Epub 2016 May 16.

PMID:
27184675
49.

The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.

Unger JM, Barlow WE, Ramsey SD, LeBlanc M, Blanke CD, Hershman DL.

JAMA Oncol. 2016 Jul 1;2(7):875-81. doi: 10.1001/jamaoncol.2015.6487.

50.

Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients.

Unger JM, Hershman DL, Arnold KB, Loomba R, Chugh R, Hwang JP, O'Rourke MA, Bhadkamkar NA, Wang LX, Siegel AB, Cooley TP, Berenberg JL, Bridges BB, Ramsey SD.

Future Oncol. 2016 May;12(10):1219-31. doi: 10.2217/fon-2015-0076. Epub 2016 Mar 8.

Supplemental Content

Loading ...
Support Center